JUVÉDERM VOLBELLA® XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids

JUVÉDERM VOLBELLA® XC found to increase lip fullness and soften the appearance of lines around the mouth through one year. (1,2)* DUBLIN, June 1, 2016 /PRNewswire/ — Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM … Continue reading